Literature DB >> 20079011

[Application of interphase fluorescence in situ hybridization in the diagnosis of lymphoma].

Rui Bi1, Dong-mei Lin, Ya-ling Han, Jun Lu, Li-yan Xue, Shan Zheng, Ming-rong Wang, Ning Lü.   

Abstract

OBJECTIVE: To investigate the feasibility of interphase FISH in the routine clinicopathological practice and its values in the differential diagnosis of lymphomas.
METHODS: A total of 74 fresh tissue samples clinically suspicious of lymphoma were investigated by FISH using three probes including IgH/bcl-2, IgH/CCND1 and API2/MALT1, corresponding the translocation t(14;18), t(11;14) and t(11;18) respectively. The results of FISH were analyzed and compared with the histopathologic diagnosis.
RESULTS: Histological evaluation eventually confirmed that there were 62 cases of lymphoma and 12 cases of reactive lymphoid processes. The translocations were detected in 7 cases in 62 cases of lymphoma: 3 demonstrated t(14;18) including 2 cases of follicular lymphomas and 1 nodular sclerosing Hodgkin lymphoma. Four cases had t(11;14) including mantle cell lymphoma (2 cases), follicular lymphoma (1 case) and small cell lymphoma (1 case). A lymphoid hyperplasia case showed detectable t(14;18). All 25 cases of DLBCL showed no evidence of t(14;18). Amplification or loss of regional genes was seen more often in malignant than in the benign cases.
CONCLUSION: Interphase FISH offers useful ancillary technology that plays an important role in differential diagnosis and classification of lymphoma.

Entities:  

Mesh:

Year:  2009        PMID: 20079011

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  1 in total

1.  Molecular Evaluation of t(14;18)(bcl-2/IgH) Translocation in Follicular Lymphoma at Diagnosis Using Paraffin-Embedded Tissue Sections.

Authors:  Nur Selvi; Buket Kosova; Mine Hekimgil; Cumhur Gündüz; Burçin Tezcanlı Kaymaz; Emin Karaca; Güray Saydam; Murat Tombuloğlu; Filiz Büyükkeçeci; Seçkin Cağırgan; Yeşim Ertan; Nejat Topçuoğlu
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.